Bendamustine and Radiation Therapy in Treating Patients With Brain Metastases Caused by Solid Tumors
Status:
Completed
Trial end date:
2015-01-08
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as bendamustine, work in different ways to stop
the growth of tumor cells, either by killing the cells or by stopping them from dividing.
Stereotactic radiation therapy may be able to send x-rays directly to the tumor and cause
less damage to normal tissue.
PURPOSE: This phase I trial is studying the side effects and best dose of bendamustine when
given together with radiation therapy in treating patients with brain metastases caused by
solid tumors.